|The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study|
DW Dunstan, PZ Zimmet, TA Welborn, MP De Courten, AJ Cameron, ...
Diabetes care 25 (5), 829-834, 2002
|High-intensity resistance training improves glycemic control in older patients with type 2 diabetes|
DW Dunstan, RM Daly, N Owen, D Jolley, M De Courten, J Shaw, ...
Diabetes care 25 (10), 1729-1736, 2002
|The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies|
A Abdullah, A Peeters, M de Courten, J Stoelwinder
Diabetes research and clinical practice 89 (3), 309-319, 2010
|The prevalence of and factors associated with diabetic retinopathy in the Australian population|
RJ Tapp, JE Shaw, CA Harper, MP De Courten, B Balkau, DJ McCarty, ...
Diabetes care 26 (6), 1731-1737, 2003
|The Australian diabetes, obesity and lifestyle study (AusDiab)—methods and response rates|
DW Dunstan, PZ Zimmet, TA Welborn, AJ Cameron, J Shaw, ...
Diabetes research and clinical practice 57 (2), 119-129, 2002
|The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome|
PZ Zimmet, DJ McCarty, MP De Courten
Journal of Diabetes and its Complications 11 (2), 60-68, 1997
|Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?|
JE Shaw, PZ Zimmet, M De Courten, GK Dowse, P Chitson, H Gareeboo, ...
Diabetes care 22 (3), 399-402, 1999
|Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality|
JE Shaw, AM Hodge, M de Courten, P Chitson, PZ Zimmet
Diabetologia 42 (9), 1050-1054, 1999
|Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players|
P Zimmet, EJ Boyko, GR Collier, M de Courten
Annals of the New York Academy of Sciences 892 (1), 25-44, 1999
|Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children|
OE Odeleye, M de Courten, DJ Pettitt, E Ravussin
Diabetes 46 (8), 1341-1345, 1997
|Surveillance of risk factors for noncommunicable diseases: the WHO STEPwise approach: summary|
R Bonita, M De Courten, T Dwyer, K Jamrozik, R Winkelmann
Noncommunicable Diseases and Mental Health, World Health Organization, 2001
|The number of years lived with obesity and the risk of all-cause and cause-specific mortality|
A Abdullah, R Wolfe, JU Stoelwinder, M De Courten, C Stevenson, ...
International journal of epidemiology 40 (4), 985-996, 2011
|Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study|
P Zimmet, A Hodge, M Nicolson, M Staten, M De Courten, J Moore, ...
Bmj 313 (7063), 965-969, 1996
|Hyperleptinaemia: the missing link in the metabolic syndrome?|
M de Courten, P Zimmet, A Hodge, V Collins, M Nicolson, M Staten, ...
Diabetic Medicine 14 (3), 200-208, 1997
|Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care|
JC Seidell, HS Kahn, DF Williamson, L Lissner, R Valdez
The American journal of clinical nutrition 73 (1), 123-126, 2001
|Country actions to meet UN commitments on non-communicable diseases: a stepwise approach|
R Bonita, R Magnusson, P Bovet, D Zhao, DC Malta, R Geneau, I Suh, ...
The Lancet 381 (9866), 575-584, 2013
|WHO STEPS surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance|
World Health Organization
World Health Organization, 2005
|Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia|
D Beran, JS Yudkin, M De Courten
Diabetes care 28 (9), 2136-2140, 2005
|Foot complications in type 2 diabetes: an Australian population‐based study|
RJ Tapp, JE Shaw, MP De Courten, DW Dunstan, TA Welborn, PZ Zimmet
Diabetic medicine 20 (2), 105-113, 2003
|Impaired fasting glucose: how low should it go?|
JE Shaw, PZ Zimmet, AM Hodge, M De Courten, GK Dowse, P Chitson, ...
Diabetes Care 23 (1), 34-39, 2000